AlphaStocks

JNJ vs PFE

JOHNSON & JOHNSON vs PFIZER INC — Side-by-Side Stock Comparison

JNJ

JOHNSON & JOHNSON

6.3

Consider Buy

$263.04

PFE

PFIZER INC

4.8

Weak

$24.31

JNJ vs PFE: Which is the Better Investment?

JOHNSON & JOHNSON (JNJ) scores 6.3/10 while PFIZER INC (PFE) scores 4.8/10 on AlphaStocks' composite model. JOHNSON & JOHNSON has the higher composite rating of Consider Buy. On a P/E basis, PFIZER INC trades at 17.9x, making it the more attractively priced of the two. PFIZER INC offers more upside to its estimated fair value.

This comparison is algorithmically generated and is not financial advice.

MetricJNJPFE
Scores & Fundamentals
Composite Score6.3/104.8/10
RatingConsider BuyWeak
Price$263.04$24.31
P/E Ratio23.817.9
ROE33.3%8.7%
Market Cap$643B$139B
Fair Value$311.45$33.12
Dividend Yield1.9%7.0%
Sector Rank#186 of 1121#595 of 1121
Model Verdicts
PiotroskiNeutralAttractive
BuffettAttractiveAttractive
GrahamCautionCaution
LynchNeutralNeutral
GreenblattNeutralStrong
View full JNJanalysis →View full PFEanalysis →
Compare any two stocks →

JNJ vs PFE: Which Stock Scores Higher?

JOHNSON & JOHNSON (JNJ) and PFIZER INC (PFE) are among the most compared stocks in the Health Care sector. JNJ currently leads with a composite score of 6.3/10 (Consider Buy) compared to PFE's 4.8/10 (Weak).

The AlphaStocks composite score evaluates each stock across four dimensions: Quality (business strength measured by Piotroski F-Score and Buffett quality criteria), Value (discount to intrinsic worth using Graham, Lynch, and Greenblatt models), Momentum (6-month price trend), and Timing (a confirmation signal that requires both value and momentum to align). A higher composite score indicates stronger overall fundamentals combined with favorable market conditions.

This comparison uses the same scoring framework for both companies, ensuring an apples-to-apples evaluation. Scores are recalculated daily after market close using data from SEC filings and market prices. Read the full methodology to understand how each model contributes to the composite score.

Scores are algorithm-generated research tools, not investment recommendations. Past performance does not guarantee future results. Always do your own due diligence. Full disclaimer